Happel David 4
4 · Sagimet Biosciences Inc. · Filed Dec 8, 2023
Insider Transaction Report
Form 4
Happel David
DirectorPresident & CEO
Transactions
- Purchase
Series A Common Stock
2023-12-07$4.10/sh+1,600$6,560→ 627,100 total
Footnotes (1)
- [F1]Reflects the weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.02 per share to $4.16 per share. The Reporting Person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each price.